Call for Abstract

2nd International Conference on Epigenetics and Human Diseases, will be organized around the theme “Evolving Landscape of Epigenetics & Therapeutic Approaches for Human Diseases”

Human Diseases 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Human Diseases 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Immunological disease
  • Track 1-2Drug addiction
  • Track 1-3Mining the epitranscriptome
  • Track 1-4NGSā€based RNA modification techniques
  • Track 1-5Physiological functions of RNA modifications
  • Track 1-6RNA splicing
  • Track 2-1Behavioral epigenetics
  • Track 2-2DNA methylation
  • Track 2-3Cancer biomarkers
  • Track 2-4Molecular biomarkers
  • Track 3-1Epigenetic mechanisms
  • Track 3-2Genomes and epigenomes
  • Track 3-3Computational epigenetics
  • Track 3-4Cigarette smoking and epigenetics
  • Track 4-1Methylation inhibiting drugs
  • Track 4-2Bromodomain and inhibitors
  • Track 4-3Histone cetylase (HAT) inhibitors
  • Track 4-4Protein methyltransferase inhibitors
  • Track 4-5Epigenetics meets endocrinology
  • Track 4-6Future direction of epigenetic drugs
  • Track 5-1Epigenetic drugs
  • Track 5-2Prospects for epigenetic therapy
  • Track 5-3Clinical study of epigenetics and epitranscriptomics
  • Track 5-4Psychopathy
  • Track 5-5Social behavior of insects
  • Track 6-1Cell types
  • Track 6-2Viral vectors
  • Track 6-3Human genetic engineering
  • Track 7-1Mitocondrial DNA
  • Track 7-2Coding DNA
  • Track 7-3Crop epigenetics: hybridization and heterosis
  • Track 7-4Natural variation and ecological epigenetics
  • Track 7-5Heritability of epigenetic marks
  • Track 8-1Genomic variation in human
  • Track 8-2Cancer genomics
  • Track 8-3Cancer genome sequencing
  • Track 8-4Cancer epigenetics
  • Track 9-1Autoimmune disease
  • Track 9-2Stem cells
  • Track 9-3Behaviour plasticity
  • Track 9-4Microbial epigenetics
  • Track 10-1Epigenetics in human neurodevelopmental disorders
  • Track 10-2Epigenetic regulation of gene expression
  • Track 10-3Epigenetics in human disease prevention
  • Track 10-4Epigenetics in reproductive health
  • Track 10-5Epigenetics in cardiovascular disease
  • Track 10-6Epigenetics in nervous system
  • Track 10-7Epigenetics modification
  • Track 11-1Epigenetic clock
  • Track 11-2Epigenetic memory
  • Track 11-3Epigenetic changes in aging
  • Track 11-4DNA methylation changes during aging
  • Track 11-5Histone modification changes during aging
  • Track 12-1Animal cloning epigenetics
  • Track 12-2Animals models in epigenetic research
  • Track 12-3Animal epigenetics examples
  • Track 12-4Animal epigenetics welfare
  • Track 13-1Molecular cytogenetics
  • Track 13-2Cytotaxonomy
  • Track 13-3Cancer cytogenetics
  • Track 13-4Fluorescent in situ hybridization
  • Track 14-1DNA packaging
  • Track 14-2Chromosome biology in agricultute
  • Track 14-3Homo and hetero chromosome
  • Track 14-4Autosomal chromosomes
  • Track 14-5Chromosomal abnormalities
  • Track 14-6Karyotyping
  • Track 15-1Epigenetic effects of environmental exposures
  • Track 15-2Toxicoepigenetics
  • Track 15-3Epigenetics and environmental origins of cancer
  • Track 15-4Diet and the epigenome
  • Track 16-1Putatively adaptive effects
  • Track 16-2Inheritance of epigenetic marks
  • Track 16-3Deleterious effects
  • Track 17-1Instruments used in epigenetics
  • Track 17-2Epigenetics products